Evolv Technologies Holdings, Inc.
Stockholder Alert: Robbins LLP Reminds EVLV Stockholders of Upcoming May 24, 2024 Lead Plaintiff Deadline in the Evolv Technologies Holdings, Inc. Class Action
09 mai 2024 15h17 HE | Robbins LLP
Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
Evolv Technologies Holdings, Inc investors: Please contact the Portnoy Law Firm to recover your losses; May 24, 2024 deadline
01 mai 2024 18h49 HE | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Evolv Technologies Holdings,...
Evolv Technologies Holdings, Inc.
EVLV Stockholders Should Contact Robbins LLP for Information about the Evolv Technologies Holdings, Inc. Class Action
15 avr. 2024 16h51 HE | Robbins LLP
Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
Evolv Technologies Holdings, Inc.
EVLV Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Evolv Technologies Holdings, Inc. Class Action
05 avr. 2024 13h27 HE | Robbins LLP
Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
Evolv Technologies Holdings, Inc investors: Please contact the Portnoy Law Firm to recover your losses; May 24, 2024 deadline
26 mars 2024 17h02 HE | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 26, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Evolv Technologies Holdings,...
Evolv Technologies Holdings, Inc.
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Evolv Technologies Holdings, Inc. f/k/a Newhold Investment Corp.
26 mars 2024 15h56 HE | Robbins LLP
Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products